Evidence map›Paper›PMID 35644057›Full record

ArticleAddictive behaviors2022

Delta-8 THC use in US adults: Sociodemographic characteristics and correlates.

Ofir Livne, Alan Budney, Jacob Borodovsky, Claire Walsh, Dvora Shmulewitz, David S Fink, Cara A Struble, Mohammad Habib, Efrat Aharonovich, Deborah S Hasin

Open access · greenAbstract read
In one paragraph

Article in Addictive behaviors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Correlates of Derived Cannabis Product Awareness, Knowledge, Use, and Use Intentions Among Young Adults.Health education & behavior : the official publication of the Society for Public Health Education · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ofir LivneDepartment of Epidemiology, Columbia University man School of Public Health, New York, NY, United States; New York State Psychiatric Institute, New York, NY, United States.
Alan BudneyDepartment of Psychiatry, Dartmouth Geisel School of Medicine, One Medical Center Drive, Lebanon, NH, United States.
Jacob BorodovskyDepartment of Psychiatry, Dartmouth Geisel School of Medicine, One Medical Center Drive, Lebanon, NH, United States.
Claire WalshNew York State Psychiatric Institute, New York, NY, United States.
Dvora ShmulewitzNew York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, United States.
David S FinkNew York State Psychiatric Institute, New York, NY, United States.
Cara A StrubleDepartment of Psychiatry, Dartmouth Geisel School of Medicine, One Medical Center Drive, Lebanon, NH, United States.
Mohammad HabibDepartment of Psychiatry, Dartmouth Geisel School of Medicine, One Medical Center Drive, Lebanon, NH, United States.
Efrat AharonovichNew York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, United States.
Deborah S HasinDepartment of Epidemiology, Columbia University man School of Public Health, New York, NY, United States; New York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, United States. Electronic address: dsh2@cumc.columbia.edu.
Dartmouth College · USNew York State Psychiatric InstituteNew York Psychoanalytic Society and Institute · US

Funding

Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
Substance Abuse Epidemiology Training Program (SAETP) at Columbia UniversityT32DA031099 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEBORAH S HASIN, Silvia Saboia Martins · 2012 to 2026
$6.1M
Training in the Science of Co-Occurring DisordersT32DA037202 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2014 to 2026
$4.7M
Leveraging Social Media to Develop the Cannabis Exposure Index (CEI), A Standardized Measure of Cannabis UseR01DA050032 · NIDA · DARTMOUTH COLLEGE · PI Jacob T Borodovsky, DEBORAH S HASIN · 2020 to 2026
$3.8M
NIDA NIH HHS P30 DA029926NIDA NIH HHS R01 DA050032NIDA NIH HHS T32 DA031099NIDA NIH HHS T32 DA037202
6 · The paper itself

Abstract

backgroundUse of novel cannabis products whose primary active compound is Delta-8 tetrahydrocannabinol (Delta-8 THC), an isomer of Delta-9 THC has recently surged. While Delta-8 THC has psychoactive effects and is potentially harmful, little is known about its use. We examined sociodemographic characteristics, motivations, and consumption patterns of Delta-8 THC in US adult cannabis users.

methodsCannabis-using adult online survey participants (N = 4,348) provided information on Delta-8 use, and other characteristics. We assessed frequencies of sociodemographics, patterns, and correlates of Delta-8 THC use. Regression models estimated adjusted odds ratios (aOR) and 95% confidence intervals (CI) of associations between past 30-day Delta-8 THC use, sociodemographic and other characteristics.

findingsAmong past 30-day cannabis users, 16.7% reported Delta-8 THC use. The most common consumption method was vaping concentrated formulations of Delta-8 THC (41.2%). Primary motivations for use were its legal status and perceived therapeutic benefits. Males were more likely than females to report Delta-8 THC use (aOR = 1.4, 95% CI 1.2, 1.7). Respondents residing in states with restrictions on sales of Delta-8 THC products had lower odds of Delta-8 THC use (aOR = 0.7, 95% CI 0.57, 0.86).

conclusionsFindings provide initial insight into the current state of Delta-8 THC use in the US. Given the limited knowledge on use of Delta-8 THC, and considering emergence of reports indicating its harmful effects, there is urgent need for nationally representative data to investigate correlates of Delta-8 THC use (e.g., effectiveness of state-specific restrictions on its products). Such information can guide public-health policy around Delta-8 THC use.

Indexed as

CannabisHallucinogensVapingAdultCommerceDronabinolFemaleHumansMaleDronabinolHallucinogensCannabisDelta-8 THCHempMarijuanaTetrahydrocannabinolWeed

Identifiers

PMID35644057
PMCPMC9245337
OpenAlexW4281391725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.